Evidence map›Paper›PMID 37146298›Full record

ReviewBlood transfusion = Trasfusione del sangue2023

Recent advances in microfluidic cell separation to enable centrifugation-free, low extracorporeal volume leukapheresis in pediatric patients.

Mubasher Iqbal, Anton Mukhamedshin, Dalia L Lezzar, Kumar Abhishek, Alexandra L McLennan, Fong W Lam, Sergey S Shevkoplyas

Open access · greenAbstract readReview
In one paragraph

Review in Blood transfusion = Trasfusione del sangue, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mubasher IqbalDepartment of Biomedical Engineering, University of Houston, Houston, TX, United States of America.
Anton MukhamedshinDepartment of Biomedical Engineering, University of Houston, Houston, TX, United States of America.
Dalia L LezzarDepartment of Biomedical Engineering, University of Houston, Houston, TX, United States of America.
Kumar AbhishekDepartment of Biomedical Engineering, University of Houston, Houston, TX, United States of America.
Alexandra L McLennanDivision of Pediatric Critical Care Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Fong W LamDivision of Pediatric Critical Care Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Sergey S ShevkoplyasDepartment of Biomedical Engineering, University of Houston, Houston, TX, United States of America.
University of Houston · US

Funding

Enabling pediatric leukapheresis with high-throughput microfluidic technologyR01HL151858 · NHLBI · UNIVERSITY OF HOUSTON · PI SHEVKOPLYAS, SERGEY S · 2020 to 2023
$1.6M
NHLBI NIH HHS R01 HL151858
6 · The paper itself

Abstract

Leukapheresis is a common extracorporeal procedure for leukodepletion and cellular collection. During the procedure, a patient's blood is passed through an apheresis machine to separate white blood cells (WBCs) from red blood cells (RBCs) and platelets (PLTs), which are then returned to the patient. Although it is well-tolerated by adults and older children, leukapheresis poses a significant risk to neonates and low-weight infants because the extracorporeal volume (ECV) of a typical leukapheresis circuit represents a particularly large fraction of their total blood volume. The reliance of existing apheresis technology on centrifugation for separating blood cells limits the degree to which the circuit ECV could be miniaturized. The rapidly advancing field of microfluidic cell separation holds excellent promise for devices with competitive separation performance and void volumes that are orders of magnitude smaller than their centrifugation-based counterparts. This review discusses recent advancements in the field, focusing on passive separation methods that could potentially be adapted to perform leukapheresis. We first outline the performance requirements that any separation method must meet to replace centrifugation-based methods successfully. We then provide an overview of the passive separation methods that can remove WBCs from whole blood, focusing on the technological advancements made in the last decade. We describe and compare standard performance metrics, including blood dilution requirements, WBC separation efficiency, RBC and PLT loss, and processing throughput, and discuss the potential of each separation method for future use as a high-throughput microfluidic leukapheresis platform. Finally, we outline the primary common challenges that must still be overcome for these novel microfluidic technologies to enable centrifugation-free, low-ECV leukapheresis in the pediatric setting.

Indexed as

Blood Component RemovalLeukapheresisAdolescentAdultCell SeparationCentrifugationChildHumansInfant, NewbornMicrofluidics

Identifiers

PMID37146298
PMCPMC10645346
OpenAlexW4372331788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.